The new pharmacy regulator, the General Pharmaceutical Council (GPhC) has publicly stated that its expertise is in regulation and not in pharmacy practice. Despite this admission, and the strong representations from representative bodies within the profession, it is proposing without consultation, to fundamentally change pharmacy practice in the way the most potent medicines are sold to the public.

We believe that selling potent medicines on an open display puts patient safety at risk and the GPhC’s proposals, which will enable P category medicines to be made available through self-selection, must be withdrawn.

Click here to read more about why the PDA are concerned about these proposals

The Pharmacists' Defence Association